These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
576 related items for PubMed ID: 23840146
21. The effect of weight loss on body composition, serum bone markers, and adipokines in prepubertal obese children after 1-year intervention. Gajewska J, Ambroszkiewicz J, Klemarczyk W, Chełchowska M, Weker H, Szamotulska K. Endocr Res; 2018 May; 43(2):80-89. PubMed ID: 29192796 [Abstract] [Full Text] [Related]
22. Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents. Mosca A, Fintini D, Scorletti E, Cappa M, Paone L, Zicari AM, Nobili V, Byrne CD. Liver Int; 2018 Dec; 38(12):2301-2308. PubMed ID: 30176114 [Abstract] [Full Text] [Related]
23. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. Ito S, Yukawa T, Uetake S, Yamauchi M. Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172 [Abstract] [Full Text] [Related]
24. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. Fracanzani AL, Petta S, Lombardi R, Pisano G, Russello M, Consonni D, Di Marco V, Cammà C, Mensi L, Dongiovanni P, Valenti L, Craxì A, Fargion S. Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682 [Abstract] [Full Text] [Related]
25. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH). Krawczyk K, Szczesniak P, Kumor A, Jasinska A, Omulecka A, Pietruczuk M, Orszulak-Michalak D, Sporny S, Malecka-Panas E. J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485 [Abstract] [Full Text] [Related]
26. Adipokines and cytokines in non-alcoholic fatty liver disease. Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M, Bennett C, Fang Y, Elariny H, Goodman Z, Chandhoke V, Younossi ZM. Aliment Pharmacol Ther; 2008 Mar 01; 27(5):412-21. PubMed ID: 18081738 [Abstract] [Full Text] [Related]
27. T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease. Pacifico L, Martino MD, Catalano C, Panebianco V, Bezzi M, Anania C, Chiesa C. World J Gastroenterol; 2011 Jul 07; 17(25):3012-9. PubMed ID: 21799647 [Abstract] [Full Text] [Related]
30. Relationships of acylated and des-acyl ghrelin levels to bone mineralization in obese children and adolescents. Pacifico L, Anania C, Poggiogalle E, Osborn JF, Prossomariti G, Martino F, Chiesa C. Bone; 2009 Aug 07; 45(2):274-9. PubMed ID: 19393347 [Abstract] [Full Text] [Related]
31. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease. Lebensztejn DM, Wojtkowska M, Skiba E, Werpachowska I, Tobolczyk J, Kaczmarski M. Adv Med Sci; 2009 Aug 07; 54(2):177-82. PubMed ID: 20022856 [Abstract] [Full Text] [Related]
32. Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation. Zhu X, Yan H, Chang X, Xia M, Zhang L, Wang L, Sun X, Yang X, Gao X, Bian H. BMJ Open Diabetes Res Care; 2020 Aug 07; 8(1):. PubMed ID: 32759166 [Abstract] [Full Text] [Related]
33. Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Moon SS, Lee YS, Kim SW. Endocrine; 2012 Oct 07; 42(2):423-9. PubMed ID: 22407492 [Abstract] [Full Text] [Related]
36. The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury: a study in the general population. Zelber-Sagi S, Ratziu V, Zvibel I, Goldiner I, Blendis L, Morali G, Halpern Z, Oren R. Eur J Gastroenterol Hepatol; 2012 Mar 07; 24(3):262-9. PubMed ID: 22246329 [Abstract] [Full Text] [Related]